Yarjejeniyar FDA ta kwanan nan ta haɗa da magunguna don jarabar opioid, ƙaura, MS

Labarai

Samun yardar magani daga FDA ya haɗa da tsari mai ƙayyadadden tsari wanda ke buƙatar kamfanoni su kammala gwaje-gwaje masu yawa, cika aikace-aikace iri-iri, kuma a ƙarshe suyi wasan jira don gano ko za su iya ci gaba tare da tallace-tallace. Dukkanin, yana ɗaukar kimanin shekaru 10 don magani don karɓar amincewar FDA, kuma kwanan nan kasuwa ta ga sabbin abubuwan amincewa waɗanda ke ba da sakamako mai kyau ga marasa lafiya tare da takamaiman yanayi.

Lucemyra don maganin jaraba na opioid

Kwararrun likitocin jiyya sun daɗe da dogara da takamaiman magunguna don taimakawa marasa lafiya da shan ƙwayoyi; duk da haka, waɗannan magungunan na iya haifar da nasu tasirin na wani lokacin. A mafi yawan lokuta, ana amfani da opioids a matsayin wani ɓangare na magani-taimaka magani , inda magungunan suka haɗu tare da wasu dabarun warkarwa don taimakawa mutane su daina dogaro.

Koyaya, cin zarafin opioid da rashin amfani da kyau suna ko'ina cikin ƙasar. A cikin 2016 kadai, Mutane 116 suka mutu kowace rana sakamakon yawan shan inna na opioid. A kokarin taimakawa wannan annoba, da FDA kawai ta ba da izini don lofexidine

Kasuwa kamar Lucemyra , lofexidine magani ne wanda aka tsara don maye gurbin opioids da dogaro wanda yazo tare dasu yayin da marasa lafiya ke wucewa ta hanyar cirewa. Ofaya daga cikin mahimman fa'idodin wannan magani shi ne cewa an ƙirƙira shi ta yadda mutane ba za su iya kamu da shi ba, kuma an nuna shi babban alƙawari a saitunan gwajin asibiti.

Gilenya don maganin sclerosis da yawa

Wani ci gaba a cikin kasuwar magunguna ya zo tare da FDA fadada yarda da Gilenya , wani magani wanda aka fara amincewa dashi a 2010 don magance manya tare da sake kamuwa da cututtukan sclerosis. Fadadawar ta ba da damar amfani da shi don kula da marasa lafiyar yara masu shekaru 10 zuwa sama waɗanda ke fama da cutar sake kamuwa da cutar sclerosis. Kodayake yawancin mutane suna bincikar cutar ta MS tsakanin shekaru 20 zuwa 50, yara waɗanda ke fama da wannan yanayin sukan sami ƙarancin ƙarancin rayuwa.

Magungunan sclerosis da yawa suna tattare da yawan bayyanar cututtuka (kamar ciwo, rawar jiki, jiri, wahalar tafiya, da sauransu) waɗanda ke gudana da gudana. A matsayin cuta na rashin lafiya na yau da kullun, yana tsangwama tare da hanyoyin sadarwa tsakanin kwakwalwar ku da jikin ku.

Aimovig don maganin ƙaura

Fiye da mutane miliyan 38 ke fama da ƙaura a cikin Amurka Baya ga yawan jin zafi na kai, mutanen da ke fuskantar ƙaura sau da yawa suna ganin suna da matuƙar saurin jin sauti da haske, kuma suna iya fuskantar tashin zuciya, amai, da hangen nesa.

Marasa lafiya da ke fama da ƙaura suna ƙoƙari, sau da yawa ba tare da nasara ba, magunguna daban-daban, gami da magunguna da magunguna daban-daban don rigakafi ko magani. A tsakiyar watan Mayu, FDA ta amince maganin allura na wata-wata da nufin hanawa ƙaura .

Masana sun gano cewa wadatar shekara-shekara na Aimovig zai kashe $ 6,900 kuma yayin da yake yiwa marasa lafiya alkawarin taimako daga alamomin da ke damun rayuwar su ta yau da kullun, yana zuwa kusan $ 600 a kowane wata.